antiprogestin (Evestra)

N/A

Report date: 2025/03/18 16:29:24

NME

Base Information

Drug Nameantiprogestin (Evestra)

Drug Alias NameEC-312

ClassificationSmall molecules > Steroids

Mechanisms of ActionProgesterone receptor modulators

TargetsProgesterone receptor

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEvestra Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEvestra Inc

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

ATC CodeN/A